Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Jump to: 2022 | 2018
Number of items: 2.

2022

Goekbuget, Nicola, Fiedler, Walter, Alakel, Nael, Topp, Max S., Hanoun, Maher, Steffen, Bjoern, Waesch, Ralph, Viardot, Andreas, Nachtkamp, Kathrin, Stelljes, Matthias, Poeck, Hendrik, Vucinic, Vladan, Boell, Boris, Beck, Joachim, Fransecky, Lars, Wendelin, Knut, Schneller, Folker, Faul, Christoph, Buecklein, Veit L., Reiser, Lena, Brueggemann, Monika, Serve, Hubert and Schwartz, Stefan (2022). Results of the Risk-Adapted, MRD-Stratified GMALL Trial 08/2013 in 281 T-ALL/T-Lbl Patients: Excellent Outcome of Standard Risk Thymic T-ALL. Blood, 140. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

2018

Schroeder, Thomas Michael, Rautenberg, Christina, Christopeit, Max, Stelljes, Matthias, Schmidt, Eva, Groth, Christoph, Scheid, Christoph, Holtick, Udo, Klein, Stefan A., Beelen, Dietrich W., Nachtkamp, Kathrin, Haas, Rainer, Germing, Ulrich, Kroeger, Nicolaus and Kobbe, Guido (2018). Treatment of MDS, AML and CMML Relapse after Allogeneic Blood Stem Cell Transplantation with Azacitidine, Lenalidomide and Donor Lymphocyte Infusions Results from the Second Interim Analysis of the Prospective Azalena-Trial (NCT02472691). Blood, 132. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

This list was generated on Fri Mar 29 09:30:21 2024 CET.